$161.51 +0.92 (%) Valeant Pharmaceuticals International Inc - NYSE

Jan. 29, 2015 | 04:00 PM

Partner Headlines

  1. IBD 50 Turns In Solid Week As Market Uptrend Resumes

    IBD | Jan. 23, 2015 | 18:34PM EST
  2. New Guru Jana Partners' Newest Stock Buys

    GuruFocus | Jan. 22, 2015 | 21:05PM EST
  3. Salix Pharma Reportedly Exploring Sale; Stock Up

    IBD | Jan. 20, 2015 | 15:06PM EST
  4. 3 Reasons To Be Bullish On Generic Drug Firm Akorn

    IBD | Jan. 15, 2015 | 14:12PM EST
  5. UPDATE: Morgan Stanley Reiterates, Raises Price Target On Valeant Pharmaceuticals As Jublia Formulary Concerns Are Noise

    Benzinga | Jan. 14, 2015 | 09:20AM EST
  6. Valeant CEO On Allegations Against The Company And Future M&A Deals

    Benzinga | Jan. 14, 2015 | 08:38AM EST
  7. Meet 5 Top Medical Stocks Making Waves This Week

    IBD | Jan. 14, 2015 | 08:02AM EST
  8. Stocks Turn Negative; Goodyear Triggers Sell Signal

    IBD | Jan. 13, 2015 | 15:10PM EST
  9. Celgene, Bristol-Myers Cancer Drug News Lifts Stocks

    IBD | Jan. 12, 2015 | 18:48PM EST
  10. Hot Big Caps: Valeant, Illumina, Chipotle Break Out

    IBD | Jan. 12, 2015 | 18:30PM EST
  11. Celgene Says Q4 Earnings Beat, Sees Currency Impact

    IBD | Jan. 12, 2015 | 13:12PM EST
  12. Analysts Make Bullish Ratings in Response to Valeant's Increased 2015 Guidance

    GuruFocus | Jan. 12, 2015 | 10:45AM EST
  13. Barclays Raises Valeant Pharmaceuticals' Price Target

    Benzinga | Jan. 9, 2015 | 16:35PM EST
  14. CRT Raises Price Target On Valeant Pharmaceuticals, 'Well Positioned For Growth'

    Benzinga | Jan. 9, 2015 | 10:17AM EST
  15. Valeant Surges On Guidance

    IBD | Jan. 8, 2015 | 18:56PM EST
  16. Stocks Mark Best Day In 3 Weeks As Indexes Jump 1.8%

    IBD | Jan. 8, 2015 | 17:04PM EST
  17. Stocks Finish Firmly Higher; Valeant, SunPower, Cigna Rocket

    IBD | Jan. 8, 2015 | 16:27PM EST
  18. Stocks Keep To High Ground; Chipotle Shows Strength

    IBD | Jan. 8, 2015 | 14:53PM EST
  19. Indexes Hold Big Gains; IBD 50 Growth Names Lead The Way

    IBD | Jan. 8, 2015 | 13:21PM EST
  20. Stock Market Surges; Nasdaq, S&P 500 Retake 50-Day Lines

    IBD | Jan. 8, 2015 | 10:23AM EST
  21. Morning Market Gainers

    Benzinga | Jan. 8, 2015 | 09:45AM EST
  22. Will Allergan Buy Help Actavis Extend Growth Streak?

    IBD | Jan. 6, 2015 | 18:17PM EST
  23. Stocks Start New Year With Gains; Intel Jumps

    IBD | Jan. 2, 2015 | 10:31AM EST
  24. These 5 Big Caps Saw Sales Surge Last Quarter

    IBD | Dec. 31, 2014 | 08:02AM EST
  25. Cantor Sees Possible Acquisitions For Valeant Pharmaceuticals In 2015

    Benzinga | Dec. 30, 2014 | 15:00PM EST
  26. Will 2015 Be Different For Big Cap Stocks?

    IBD | Dec. 29, 2014 | 17:27PM EST
  27. Are There Any Winners Left In The Biotech Space?

    Benzinga | Dec. 24, 2014 | 13:01PM EST
  28. Fresh Milestones For Dow, S&P 500 But Biotechs Hit

    IBD | Dec. 23, 2014 | 14:48PM EST
  29. Actavis, Valeant Largely Avoid Gilead's Hepatitis Dive

    IBD | Dec. 22, 2014 | 18:23PM EST
  30. Energy Sector Seen as Biggest Risk to Deal Flow in 2015

    FoxBusiness | Dec. 22, 2014 | 09:00AM EST
  31. Great Stocks: Valeant Pharmaceuticals Near Buy Point

    IBD | Dec. 16, 2014 | 18:11PM EST
  32. Index-Crushing Fund Buys Fastenal During Sell-Off

    YCharts | Dec. 10, 2014 | 10:38AM EST
  33. Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO

    Benzinga | Dec. 9, 2014 | 15:02PM EST
  34. Where Could ValueAct Capital's New $1.5 Billion Go?

    Benzinga | Dec. 9, 2014 | 13:38PM EST
  35. Stock Market Today: Wall Street Drops; Conn's Down 40%

    IBD | Dec. 9, 2014 | 11:55AM EST
  36. US Stock Futures Slip Ahead Of Wholesale Inventories Data

    Benzinga | Dec. 9, 2014 | 07:12AM EST
  37. Valeant Abandoning its Growth by Acquisition Strategy -Reuters

    Benzinga | Dec. 9, 2014 | 05:13AM EST
  38. Two Gauges That Point To Fund Buying In A Stock

    IBD | Dec. 8, 2014 | 18:18PM EST
  39. Inside The IBD 50: Challenging Time For Growth Stocks

    IBD | Dec. 5, 2014 | 18:54PM EST
  40. Some Big Cap 20 Names Holding Up In Monday's Sell-Off

    IBD | Dec. 1, 2014 | 18:58PM EST
  41. Valeant Rises After Allergan Snub; Zeltiq In Buy Area

    IBD | Nov. 19, 2014 | 18:14PM EST
  42. Benzinga's M&A Chatter for Tuesday November 18, 2014

    Benzinga | Nov. 18, 2014 | 19:34PM EST
  43. Stocks Hit New Milestones; BitAuto Rebounds

    IBD | Nov. 18, 2014 | 16:17PM EST
  44. Zoetis 2015 Guidance Misses As Buyout Theories Abound

    IBD | Nov. 18, 2014 | 15:15PM EST
  45. Stock Movers: Why 4 Big Drug Stocks Are Rising Today

    IBD | Nov. 18, 2014 | 14:38PM EST
  46. Bill Ackman Says He Supports The Allergan-Actavis Deal And CEO Brent Saunders

    Benzinga | Nov. 18, 2014 | 14:17PM EST
  47. Stocks Hold Near Fresh Milestones; Actavis Hits New High

    IBD | Nov. 18, 2014 | 13:33PM EST
  48. Ackman Pledges Support For Actavis Bid On Allergan

    Benzinga | Nov. 18, 2014 | 13:10PM EST
  49. Is Bill Ackman Back?

    Benzinga | Nov. 18, 2014 | 10:56AM EST
  50. Stocks Climb In Mixed Trade; First Wind Deal Lifts SunEdison

    IBD | Nov. 18, 2014 | 10:35AM EST
Trading Center